Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol effect on sevoflurane requirement and postoperative recovery under Narcotrend monitoring
ChiCTR-IPR-15005951Phase 2Recruiting
- Sponsor
- Tongji Hospital
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of esmolol and sevoflurane in Not applicable (2 arms), sponsored by Tongji Hospital. Primary endpoint: Requirement of sevoflurane. Started Feb 2015; status: recruiting.
02
Drugs
esmololsevoflurane
03
Conditions
Not applicable
Beyond the preview
Go deeper on ChiCTR-IPR-15005951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005951.